November 17, 2016 - By Vivian Park · 0 Comments
The stock of Thermo Fisher Scientific Incorporated (NYSE:TMO) registered an increase of 11.04% in short interest. TMO’s total short interest was 5.17 million shares in November as published by FINRA. Its up 11.04% from 4.66 million shares, reported previously. With 1.90 million shares average volume, it will take short sellers 3 days to cover their TMO’s short positions. The short interest to Thermo Fisher Scientific Incorporated’s float is 1.32%. About 1.02 million shares traded hands. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 2.86% since April 15, 2016 and is uptrending. It has underperformed by 1.77% the S&P500.
Thermo Fisher Scientific Inc. develops, makes and sells a range of products. The company has a market cap of $59.30 billion. The Firm is a well-known provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It has a 29.67 P/E ratio. The firm operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Insitutional Activity: The institutional sentiment is 0.97 in Q2 2016. Its the same as in 2016Q1. The ratio is without change, as 41 funds sold all Thermo Fisher Scientific Inc. shares owned while 373 reduced positions. only 78 funds bought stakes while 324 increased positions. They now own 337.36 million shares or 4.63% less from 353.72 million shares in 2016Q1.
Teachers has 974,349 shares for 0.25% of their US portfolio. Private Wealth Ptnrs Lc owns 52,735 shares or 1.87% of their US portfolio. Carderock Management has invested 2.31% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Virginia Retirement Et Al holds 0.25% or 112,800 shares in its portfolio. Rockland Tru owns 25,782 shares or 0.66% of their US portfolio. Ferguson Wellman Cap Incorporated owns 142,931 shares or 0.89% of their US portfolio. Hermes Inv Limited, a United Kingdom-based fund reported 316,837 shares. Private Advisor Lc accumulated 12,415 shares or 0.07% of the stock. Vsr Financial accumulated 0.05% or 1,875 shares. Wfg Advisors L P accumulated 120 shares or 0% of the stock. Hbk Sorce Advisory Llc last reported 4,716 shares in the company. Kbc Nv last reported 0.54% of its portfolio in the stock. Ww Asset Mngmt, a Michigan-based fund reported 37,634 shares. Cam Grp Hldg A S accumulated 0.21% or 73,640 shares. New Mexico Educational Retirement Board accumulated 0.31% or 45,862 shares.
Insider Transactions: Since May 24, 2016, the stock had 0 buys, and 18 insider sales for $38.79 million net activity. The insider Shine Daniel P sold 476 shares worth $72,247. $495,824 worth of shares were sold by Loewald Thomas W on Monday, August 29. CASPER MARC N sold $3.90M worth of stock. $783,588 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by HOOGASIAN SETH H on Wednesday, August 10. Shares for $61,359 were sold by HARRIS C MARTIN. WILVER PETER M had sold 68,200 shares worth $10.39 million. Williamson Stephen sold 8,660 shares worth $1.30M.
Out of 13 analysts covering Thermo Fisher Scientific (NYSE:TMO), 11 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 85% are positive. Thermo Fisher Scientific has been the topic of 27 analyst reports since July 24, 2015 according to StockzIntelligence Inc. As per Tuesday, October 6, the company rating was initiated by Argus Research. The stock has “Buy” rating given by BTIG Research on Friday, July 22. JP Morgan initiated the shares of TMO in a report on Thursday, September 22 with “Overweight” rating. The rating was downgraded by Jefferies to “Hold” on Friday, April 29. Mizuho maintained it with “Buy” rating and $160 target price in Thursday, July 23 report. As per Friday, May 27, the company rating was maintained by Mizuho. On Tuesday, May 3 the stock rating was maintained by Mizuho with “Buy”. The firm earned “Neutral” rating on Friday, September 9 by Cleveland. The rating was initiated by Deutsche Bank with “Buy” on Thursday, January 7. The rating was maintained by Stifel Nicolaus on Monday, January 11 with “Buy”.
Thermo Fisher Scientific Inc., incorporated on October 11, 1960, develops, makes and sells a range of products. The Firm is a well-known provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The firm operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Firm serves its clients through its brands, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. The Thermo Scientific brand offers clients in research, diagnostics, industrial and applied markets analytical instruments, as well as laboratory equipment, software, services, consumables and reagents.
More important recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Wsj.com which released: “Thermo Fisher Scientific Lifts Outlook” on October 27, 2016, also Finance.Yahoo.com published article titled: “Biocartis Group NV: Thermo Fisher Scientific to Distribute Biocartis’ Idylla …”, Businesswire.com published: “Thermo Fisher Scientific Submits Premarket Approval Application to FDA for …” on November 14, 2016. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) was released by: Equitiesfocus.com and their article: “Thermo Fisher Scientific Inc (NYSE:TMO) Short-Term Price Target At $174.17” with publication date: November 16, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park